To amend title XI of the Social Security Act to clarify manufacturer transparency reporting requirements for certain transfers used for educational purposes.

HR 4402 clarifies transparency reporting requirements for pharmaceutical manufacturers. It adds specific educational materials - like peer-reviewed journals, journal reprints, medical conference reports, and textbooks - to the list of items manufacturers must report when transferring value to healthcare providers. This change directly affects drug manufacturers who provide these educational resources to doctors or institutions. The bill expands existing reporting rules under the Social Security Act to ensure greater transparency about such transfers. The amendment applies to transfers made on or after the law's enactment date.